Tiltan Pharma's Bridge Round

Tiltan Pharma raised a round of funding on September 09, 2010. Investors include Israel Innovation Authority.

Tiltan Pharma is a biotechnology company dedicated to the development and commercialization of its proprietary anti-angiogenic platform for the treatment of cancer and other indications. The Company i…

Articles about Tiltan Pharma's Bridge Round: